Halberd Co. (OTCMKTS:HALB) Sees Significant Increase in Short Interest

Halberd Co. (OTCMKTS:HALB) saw a significant increase in short interest in June. As of June 15th, there was short interest totaling 409,891 shares, an increase of 208.2% from the May 31st total of 133,008 shares. Based on an average daily trading volume, of 1,861,083 shares, the short-interest ratio is currently 0.2 days.

Halberd Price Performance

Shares of OTCMKTS:HALB remained flat at $0.00 during trading on Friday. 18,050 shares of the stock were exchanged, compared to its average volume of 775,667. Halberd has a 52 week low of $0.00 and a 52 week high of $0.00.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.